𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Evidence of thalamic dysfunction in Huntington disease by proton magnetic resonance spectroscopy

✍ Scribed by Heloísa H. Ruocco; Iscia Lopes-Cendes; Li M. Li; Fernando Cendes

Publisher
John Wiley and Sons
Year
2007
Tongue
English
Weight
111 KB
Volume
22
Category
Article
ISSN
0885-3185

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Our objective was to investigate thalamic neuronal dysfunction in patients with Huntington disease (HD). We performed localized single‐voxel proton magnetic resonance spectroscopy (MRS) of the thalamus in 22 HD patients and 25 healthy individuals. The mean age of patients was 48.5 years (ranging from 32 to 71 years). Age at onset varied between 20 and 66 years (mean 38.9 years). The expanded CAG repeat ranged from 40 to 52 (mean 45.2) CAGs. The mean age of control group was 35.4 years, ranging from 19 to 67 years. N‐acetylaspartate (NAA) relative to creatine (NAA/Cr) values in the thalamus of HD patients were decreased when compared with controls (P = 0.0001). The spectroscopic findings were not correlated with motor impairment. However, there was a positive correlation between duration of disease and motor impairment (P = 0.02, r = 0.48), and a tendency for positive correlation between duration of disease and NAA/Cr (P = 0.059, r = 0.4). We found decreased NAA/Cr values in the thalamus of patients with HD, indicating neuronal loss or dysfunction. This is in agreement with previous studies that indicated the involvement of mitochondrial dysfunction in the neurodegenerative process of HD. © 2007 Movement Disorder Society

📜 SIMILAR VOLUMES

Use of proton nuclear magnetic resonance
Use of proton nuclear magnetic resonance spectroscopy of plasma in screening for malignant disease
✍ Shigeki Ono; Fuminori Moriyasu; Motoshige Nabeshima; Kozo Kajimura; Yukitaka Yam 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 707 KB

In 1986, narrow plasma proton nuclear magnetic resonance (NMR) methyl and methylene line widths were reported to be associated with malignant disease, but more recent studies have not confirmed this relationship. The authors analyzed 106 plasma samples from healthy control subjects and patients with

Assessment of normal fetal brain maturat
Assessment of normal fetal brain maturation in utero by proton magnetic resonance spectroscopy
✍ Nadine Girard; Sylviane Confort Gouny; Angèle Viola; Yann Le Fur; Patrick Viout; 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 406 KB 👁 1 views

## Abstract Cerebral maturation in the normal human fetal brain was investigated by in utero localized proton MR spectroscopy (^1^H MRS). Fifty‐eight subjects at 22–39 weeks of gestational age (GA) were explored. A combination of anterior body phased‐array coils (four elements) and posterior spinal

Unchanged basal ganglia N-acetylaspartat
Unchanged basal ganglia N-acetylaspartate and glutamate in idiopathic Parkinson's disease measured by proton magnetic resonance spectroscopy
✍ Dr. C. E. Clarke; M. Lowry; A. Horsman 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 498 KB

## Abstract The lentiform nucleus of five patients with idiopathic Parkinson's disease (IPD) was studied by quantitative magnetic resonance spectroscopy (MRS), both before and after administration of apomorphine, and the spectra were compared with those from a group of age‐matched normal subjects.

Proton magnetic resonance spectroscopy o
Proton magnetic resonance spectroscopy of human brain in vivo in the evaluation of multiple sclerosis: Assessment of the load of disease
✍ Douglas L. Arnold; Paul M. Matthews; Gordon Francis; Jack Antel 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 299 KB 👁 1 views

## Abstract Image localized, water‐suppressed proton magnetic resonance spectra were obtained from affected brain in patients with multiple sclerosis. In patients with moderate to severe chronic disease, spectra revealed a decreased ratio of __N__‐acetylaspartate to creatine resonance intensities.